David Lambeth

Corporate Officer/Principal at Emory University School of Medicine

Consumer Services

Health Technology

Profile

David Lambeth is the founder of Calliditas Therapeutics Suisse SA, which was founded in 2006.
He is currently a Professor at Emory University School of Medicine, where he has been working since 1980.
Dr. Lambeth received a doctorate degree from Duke University.

David Lambeth active positions

Companies	Position	Start
Emory University School of Medicine	Corporate Officer/Principal	31/12/1979

All active positions of David Lambeth

Former positions of David Lambeth

Companies	Position	End
Calliditas Therapeutics Suisse SA Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.	Founder	-

See the detail of David Lambeth's experience

Training of David Lambeth

Duke University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Lambeth's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Calliditas Therapeutics Suisse SA Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.	Health Technology